首页> 外文期刊>Antiviral Research >Selective activity of various antiviral compounds against HHV-7 infection.
【24h】

Selective activity of various antiviral compounds against HHV-7 infection.

机译:各种抗病毒化合物对HHV-7感染的选择性活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Human herpesvirus virus type 7 (HHV-7) is a T-lymphotropic herpesvirus which uses the CD4 receptor as main receptor to infect its target cells. Measuring the decrease of CD4 expression during HHV-7 infection is a convenient and accurate method to monitor the efficacy of antiviral agents against HHV-7 infection. Different classes of compounds, such as heparin, pentosan polysulfate (PS), dextran sulfate (DS), aurintricarboxylic acid (ATA), phosphonoformic acid (PFA), 9-(2-phosphonylmethoxyethyl)adenine (PMEA), 2-amino-7-[(1,3-dihydroxy-2-propoxy) methyl] purine (S2242), polyvinylalcohol sulfate (PVAS) and the co-polymer of vinylalcohol sulfate with acrylic acid (PAVAS), acyclovir (ACV), ganciclovir (GCV), penciclovir (PCV), brivudin (BVDU), cidofovir (HPMPC), lobucavir, (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] (H2G), (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) and sorivudine (BVaraU), were evaluated for their anti-HHV-7 activity in the SupT1 T cell line and in purified CD4+ T lymphocytes. Antiviral activity was monitored by inhibition of: (i) CD4 expression down-regulation; (ii) giant cell formation and (iii) apoptosis induction. In general, PS, DS, PVAS, PAVAS, ATA, PFA, PMEA, S2242, lobucavir and HPMPC had comparable anti-HHV-7 activity in the two cell lines, irrespective of the parameters followed to monitor antiviral activity. One of the exceptions was heparin which had an IC50 of 9.6 microg/ml in SupT1 cells and >250 microg/ml in CD4+ T lymphocytes. The compounds PCV, GCV, H2G and PMPA showed some activity in CD4+ T lymphocytes, but not in SupT1 cells. ACV, BVDU and BVaraU did not show activity in either cell system. None of the chemokines tested, such as platelet factor-4 (PF-4), eotaxin, stromal cell-derived factor 1alpha(SDF-1alpha) and RANTES, had detectable activity against HHV-7. In contrast, the HIV-1 envelope glycoprotein, gp120, and the two anti-CD4 mAbs, 13B8-2 and OKT4, were clearly active against HHV-7 infection.
机译:7型人类疱疹病毒(HHV-7)是一种T淋巴性疱疹病毒,它使用CD4受体作为主要受体来感染其靶细胞。测量HHV-7感染过程中CD4表达的减少是监测抗病毒药对抗HHV-7感染疗效的便捷,准确的方法。不同种类的化合物,例如肝素,戊聚糖多硫酸盐(PS),硫酸葡聚糖(DS),金三羧酸(ATA),膦酸甲酸(PFA),9-(2-膦酰基甲氧基乙基)腺嘌呤(PMEA),2-氨基-7 -[[(1,3-二羟基-2-丙氧基)甲基]嘌呤(S2242),聚乙烯醇硫酸盐(PVAS)和乙烯醇硫酸盐与丙烯酸的共聚物(PAVAS),阿昔洛韦(ACV),更昔洛韦(GCV),喷昔洛韦(PCV),普罗布定(BVDU),西多福韦(HPMPC),洛布韦,(R)-9- [4-羟基-2-(羟甲基)丁基]鸟嘌呤](H2G),(R)-9-(2-在SupT1 T细胞系和纯化的CD4 + T淋巴细胞中评估了膦酰基甲氧基丙基)腺嘌呤(PMPA)和sorivudine(BVaraU)的抗HHV-7活性。通过抑制以下各项来监测抗病毒活性:(i)CD4表达下调; (ii)巨细胞形成和(iii)凋亡诱导。通常,PS,DS,PVAS,PAVAS,ATA,PFA,PMEA,S2242,lobucavir和HPMPC在这两种细胞系中具有可比的抗HHV-7活性,而与监测抗病毒活性的参数无关。肝素是例外之一,肝素在SupT1细胞中的IC50为9.6微克/毫升,在CD4 + T淋巴细胞中的IC50为> 250微克/毫升。化合物PCV,GCV,H2G和PMPA在CD4 + T淋巴细胞中显示某些活性,但在SupT1细胞中则没有。 ACV,BVDU和BVaraU在任一细胞系统中均未显示活性。测试的趋化因子,例如血小板因子4(PF-4),嗜酸性粒细胞趋化因子,基质细胞衍生因子1alpha(SDF-1alpha)和RANTES,均未检测到抗HHV-7的活性。相反,HIV-1包膜糖蛋白gp120和两种抗CD4单抗13B8-2和OKT4显然对HHV-7感染具有活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号